000 | 01252 a2200349 4500 | ||
---|---|---|---|
005 | 20250515075609.0 | ||
264 | 0 | _c20070925 | |
008 | 200709s 0 0 eng d | ||
022 | _a1110-0362 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEl Serafi, Moustafa M | |
245 | 0 | 0 |
_aGemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study. _h[electronic resource] |
260 |
_bJournal of the Egyptian National Cancer Institute _cSep 2006 |
||
300 |
_a209-15 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aGemcitabine |
700 | 1 | _aEl Khodary, Ahmed I | |
700 | 1 | _aEl Zawahry, Heba R | |
700 | 1 | _aMansour, Osman M | |
700 | 1 | _aGaballa, Hussein E | |
773 | 0 |
_tJournal of the Egyptian National Cancer Institute _gvol. 18 _gno. 3 _gp. 209-15 |
|
999 |
_c17204233 _d17204233 |